{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T23:52:28Z","timestamp":1769125948251,"version":"3.49.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Ophthalmol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The study aims to understand the disease course of optic neuritis in the Indian population and analyze their demographic patterns, clinical features, and treatment responses over a period of two decades.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively reviewed the medical records of patients with optic neuritis (ON) who presented to the neuro-ophthalmology clinic of a tertiary eye center between 1997 and 2017. Clinical profiles, neuroimaging features, and post-treatment visual outcomes were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 406 eyes from 314 patients were included in this study. The mean age at presentation was 36.28 \u00b1 12.58 years. Females were more commonly affected (N = 191patients, 60%). Unilateral involvement was noted in 70% (222 patients), and pain was associated with 63% (200 patients). The mean vision at presentation was 20\/500 \u00b1 20\/158 (log MAR 1.39 \u00b1 0.898). Optic disc edema was noted on presentation in 50% of patients (204 eyes). The mean vision post-treatment was 20\/44 \u00b1 20\/91 (log MAR 0.34 \u00b1 0.66). Recurrent optic neuritis was observed in 26.75% of patients (84 patients). Neuromyelitis optica antibody (NMO Ab) was positive in 19 patients, and myelin oligodendrocyte glycoprotein antibody (MOG Ab) was positive in one patient. Optic neuritis was of idiopathic etiology in 88.8% of patients, multiple sclerosis (MS) in 5.8%, and 4.8% had conversion to MS by 3years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This ON study group of the Indian population had more optic disc edema on presentation and visual outcomes similar to those of other Asian studies, unlike ONTT. Idiopathic ON and neuromyelitis optica spectrum disorder-optic neuritis (NMOSD-ON) were more common than MS optic neuritis (MS-ON) in this cohort population. Prospective long-term follow-up of these patients can reveal the natural disease course, neurological associations, and treatment outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fopht.2025.1688001","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:56:18Z","timestamp":1769064978000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term Indian optic neuritis study (THE LION STUDY): clinical, imaging features and visual behavior of optic neuritis in Indian population over two decades"],"prefix":"10.3389","volume":"5","author":[{"given":"Selvakumar","family":"Ambika","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santhakumar","family":"Durgapriyadarshini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikha Talwar","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Padma","family":"Lakshmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smita","family":"Praveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidhya","family":"Dharani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group","volume":"109","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2019.08.001","article-title":"Optic neuritis in the era of biomarkers","volume":"65","author":"Chen","year":"2020","journal-title":"SurvOphthalmol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000110220","article-title":"Multiple sclerosis: Indian experience in the last thirty years","volume":"4","author":"Jain","year":"1985","journal-title":"Neuroepidemiology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.103186","article-title":"Optic neuritis: experience from a south Indian demyelinating disease registry","volume":"60","author":"Pandit","year":"2012","journal-title":"Neurol India"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00200-9","article-title":"Diagnosis and classification of optic neuritis","volume":"21","author":"Petzold","year":"2022","journal-title":"Lancet Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis:2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514521503","article-title":"Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India","volume":"20","author":"Pandit","year":"2014","journal-title":"Mult Scler"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-5155(98)00072-0","article-title":"Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG)","volume":"43","author":"Wakakura","year":"1999","journal-title":"Jpn J Ophthalmol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/01658107.2011.557851","article-title":"A comparison of optic neuritis in Asian and in western countries","volume":"35","author":"Woung","year":"2011","journal-title":"Neuroophthalmology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.121131","article-title":"Clinical profile and short-term outcomes of optic neuritis patients in India","volume":"62","author":"Saxena","year":"2014","journal-title":"Indian J Ophthalmol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.04.042","article-title":"Working group on diagnostic criteria for refractory optic neuritis based on neuroimmunological perspective. Epidemiologic and clinical characteristics of optic neuritis in Japan","volume":"126","author":"Ishikawa","year":"2019","journal-title":"Ophthalmology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4103\/ijo.IJO_887_21","article-title":"Clinical profile, imaging features and short term visual outcomes of Indian optic neuritis patients with and without seromarkers for myelin oligodendrocyte glycoprotein and neuromyelitis optica","volume":"70","author":"Ambika","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-005-0281-1","article-title":"Low conversion rate to multiple sclerosis in idiopathic optic neuritis patients in Taiwan","volume":"50","author":"Lin","year":"2006","journal-title":"Jpn J Ophthalmol"},{"key":"B16","article-title":"Optic neuritis in Singapore","volume":"49","author":"Lim","year":"2008","journal-title":"Singapore Med J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"312\u22125","DOI":"10.1046\/j.1442-9071.2001.00442.x","article-title":"The presentation, aetiology, management and outcome of optic neuritis in an Asian population","volume":"29","author":"Wang","year":"2001","journal-title":"Clin Experiment Ophthalmol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.27069","article-title":"Visual outcome after intravenous dexamethasone therapy for idiopathic optic neuritis in an Indian population: a clinical case series","volume":"54","author":"Sethi","year":"2006","journal-title":"Indian J Ophthalmol"},{"key":"B19","article-title":"Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up","volume":"65","year":"2008","journal-title":"Arch Neurol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1993.01090060061023","article-title":"Optic neuritis treatment trial. One-year follow-up results","volume":"111","author":"Beck","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.5.1404","article-title":"The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial","volume":"49","year":"1997","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(94)31103-1","article-title":"The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial","volume":"101","author":"Beck","year":"1994","journal-title":"Ophthalmology"},{"key":"B23","first-page":"195","article-title":"Profile of optic neuritis in Chandigarh and surrounding areas","volume":"28","author":"Jain","year":"1981","journal-title":"Indian J Ophthalmol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S271820","article-title":"Etiologies of acute optic neuritis in Thailand: an observational study of 171 patients","volume":"14","author":"Vanikieti","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4103\/0972-2327.192389","article-title":"Serological markers associated with neuromyelitis optica spectrum disorders in South India","volume":"19","author":"Pandit","year":"2016","journal-title":"Ann Indian Acad Neurol"},{"key":"B26","article-title":"Demographic and clinical features of neuromyelitisoptica: a review","volume":"21","author":"Pandit","year":"2015","journal-title":"MultSclerJ"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-311177","article-title":"Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients","volume":"102","author":"Zhao","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.540156","article-title":"AQP4-IgG and MOG-IgG related optic neuritis-prevalence, optical coherence tomography findings, and visual outcomes: A systematic review and meta-analysis","volume":"11","author":"Filippatou","year":"2020","journal-title":"Front Neurol"}],"container-title":["Frontiers in Ophthalmology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2025.1688001\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:56:18Z","timestamp":1769064978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2025.1688001\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":28,"alternative-id":["10.3389\/fopht.2025.1688001"],"URL":"https:\/\/doi.org\/10.3389\/fopht.2025.1688001","relation":{},"ISSN":["2674-0826"],"issn-type":[{"value":"2674-0826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"article-number":"1688001"}}